Abstract
Until the 1990s, the concept of rejuvenation was reduced essentially to the absence of lines and folds. During the last decade, there have been significant advances in the technology embedded in hyaluronic acid (HA) products, as well as a refinement of application techniques that, together, also permitted the HA to become a gold standard as a volumizing agent. The main modification in the facial aesthetic treatment has been the exchange of the two-dimensional focus, to the appreciation of the three-dimensional concept, which also recognizes volumetric losses due to bone resorption, gingival retraction, and redistribution of facial fat as signs of aging. The concept is based on balance and facial harmony, respecting patients’ gender, ethnicity, and objectives, and allows for more natural results without “frozen” or distorted expressions. The aim of this chapter is to show a practical view of the use of HA for volumizing the malar region (important anatomical concepts, areas of risk, kinds of fillers and rheological concepts, techniques with needle and cannula, adverse events and treatment of complications), with literature-based information and tips from the author. The midfacial area (malar area) is the starting point for the three-dimensional approach in rejuvenation treatment. The use of HA in this area is effective and safe.
This is a preview of subscription content, log in via an institution.
References
Alijotas-Reig J, et al. Are bacterial growth and/or chemotaxis increased by filler injections? Implications for the pathogenesis and treatment of filler-related granulomas. Dermatology. 2010;221:356–64.
Andre P. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA – Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. JEADV. 2004;18:422–5.
Bergeret-Galley C. Comparison of resorbable soft tissue fillers. Aesthet Surg J. 2004;24(1):33–46.
Cassuto D. Managing filler complications. Merge on line. 2010. www.mergeonline.com.
Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg. 2008;34:S92–9.
Cohen JL, et al. Systematic review of clinical trials of small and large-gel-particle hyaluronic acid injectable fillers for aesthetic soft tissue augmentation. Dermatol Surg. 2013;39(2):205–31.
Delorenzi C, et al. A multicenter study of the efficacy and safety of subcutaneous nonanimal stabilized hyaluronic acid in Aesthetics facial contouring: interim report. Dermatol Surg. 2006;32(2):205–11.
Derek H, Jared J. Safety and efficacy of volumizing hyaluronic acid filler for treatment of HIV-associated facial lipoatrophy. JAMA Dermatol. 2016; https://doi.org/10.1001/jamadermatol.2016.3827. Published online 2 Nov 2016.
Duranti F, et al. Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg. 1998;24(12):1317–25.
Fernandes RL. Conceito tridimensional: nova tendência no tratamento estético facial. Rev Bras Med. 2011;11(4):126–8.
Fernandez-Acenero MJ, et al. Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation. Dermatol Surg. 2003;29:1225–6.
Friedman PM, et al. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft-tissue augmentation. Dermatol Surg. 2002;28(6):491–4.
Gassia V, et al. Global facial rejuvenation: perioral, nose, and ear. J Cosmet Dermatol. 2013;12(2):123–36.
Honig JF, et al. Severe granulomatous allergic tissue reaction after hyaluronic acid injection in the treatment of facial lines and its surgical correction. J Cranofacial Surg. 2003;14(2):197–200.
Lemperle G, et al. Avoiding and treating dermal filler complications. Cosmetic. 2014;118:3S.
Lowe NJ, et al. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol. 2001;45(6):930–3.
Lowe NJ, et al. Adverse reactions to dermal fillers: review. Dermatol Surg. 2005;31(11 Pt 2):1616–25.
Lupton JR, Alster TS. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg. 2000;26(2):135–7.
Matarasso SL, Carruthers JD, Jewell ML, Restylane Consensus Group. Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane®) (NASHA). Plast Reconst Surg. 2006;117:3S.
Micheels P. Human anti hyaluronic acid antibodies: is it possible? Dermatol Surg. 2001;27:185–91.
Narins RS, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29:588–95.
Olenius M. The first clinical study using a new biodegradable implant for the treatment of lips, wrinkles and folds. Aesthet Plast Surg. 1998;22:97–101.
Pons-Guirard A. Actualisation des effets secondaires des produits de comblement de rides. Nouv Dermatol. 2003;22:205–10.
Raulin C, et al. Exudative granulomatous reaction to hyaluronic acid (Hylaform®). Contact Dermatitis. 2000;43:178–9.
Rohrich R, Pessa J. The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg. 2008;119:2219–27.
Schanz S, et al. Arterial embolization caused by injection of hyaluronic acid (Restylane®). Br J Dermatol. 2002;146:928–9.
Shafir R, et al. Long-term complications of facial injections with Restylane (injectable hyaluronic acid). Plast Reconstr Surg. 2000;106(5):1215–6.
Sherman RN. Avoiding dermal filler complications. Clin Dermatol. 2009;27:S23–32.
US- FDA. Executive summary dermal fillers devices dated of 18th November 2008.
Vleggaar D, Fitzgerald R. Dermatological implications of skeletal aging: a focus on supraperiostal volumization for perioral rejuvenation. J Drugs Dermatol. 2008;7(3):209–20.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Fernandes, R.L. (2019). Hyaluronic Acid Filler for the Malar Area. In: Issa, M., Tamura, B. (eds) Botulinum Toxins, Fillers and Related Substances. Clinical Approaches and Procedures in Cosmetic Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-20253-2_20-2
Download citation
DOI: https://doi.org/10.1007/978-3-319-20253-2_20-2
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20253-2
Online ISBN: 978-3-319-20253-2
eBook Packages: Springer Reference MedicineReference Module Medicine
Publish with us
Chapter history
-
Latest
Hyaluronic Acid Filler for the Malar Area- Published:
- 31 December 2018
DOI: https://doi.org/10.1007/978-3-319-20253-2_20-2
-
Original
Hyaluronic Acid Filler for the Malar Area- Published:
- 27 February 2017
DOI: https://doi.org/10.1007/978-3-319-20253-2_20-1